Increased apolipoprotein-B:A1 ratio predicts cardiometabolic risk in patients with juvenile onset SLE-Reference-Cited by-同舟云学术

Increased apolipoprotein-B:A1 ratio predicts cardiometabolic risk in patients with juvenile onset SLE

Published:2021-03 Issue: Volume:65 Page:103243
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Robinson George A.^ORCID,Waddington Kirsty E.,Coelewij Leda,Peng Junjie,Naja Meena,Wincup Chris,Radziszewska Anna,Peckham Hannah,Isenberg David A.,Ioannou Yiannis,Ciurtin Coziana,Pineda-Torra Ines,Jury Elizabeth C.^ORCID

Funder

MRC

Rosetrees Trust

Versus Arthritis

British Heart Foundation

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference72 articles.

1. Differences in disease phenotype and severity in SLE across age groups;Ambrose;Lupus,2016

2. Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus;Hersh;Arthritis Care Res (Hoboken),2010

3. Unmet needs in the pathogenesis and treatment of systemic lupus erythematosus;Bakshi;Clin Rev Allergy Immun,2018

4. Mortality in systemic lupus erythematosus;Bernatsky;Arthritis Rheumatism,2006

5. Current causes of death in systemic lupus erythematosus in Europe, 2000—2004: relation to disease activity and damage accrual;Nossent;Lupus,2007

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Learning from serum markers reflecting endothelial activation: longitudinal data in childhood-onset systemic lupus erythematosus;Lupus Science & Medicine;2024-09

2. Phytosterols in human serum as measured using a liquid chromatography tandem mass spectrometry;The Journal of Steroid Biochemistry and Molecular Biology;2024-07

3. Gut microbiota landscape and potential biomarker identification in female patients with systemic lupus erythematosus using machine learning;Frontiers in Cellular and Infection Microbiology;2023-12-19

4. Atherosclerosis Progression in the APPLE Trial Can Be Predicted in Young People With Juvenile‐Onset Systemic Lupus Erythematosus Using a Novel Lipid Metabolomic Signature;Arthritis & Rheumatology;2023-12-19

5. Systemic lupus erythematosus patients have unique changes in serum metabolic profiles across age associated with cardiometabolic risk;Rheumatology;2023-12-04